Obstructive Hypertrophic Cardiomyopathy (oHCM)

Cardiovascular·MeSH: Cardiomyopathy, Hypertrophic
5 drugs in development·2 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)
DrugCompany
myqorzoCYTOKINETICS INC (CYTK)

Compare drugs

myqorzo vs aficamten (5 mgmyqorzo vs Metoprolol succinatemyqorzo vs metoprolol succinate (50 mg

Frequently asked questions

How many drugs are in development for Obstructive Hypertrophic Cardiomyopathy (oHCM)?

BioSniper tracks 5 drugs in development for Obstructive Hypertrophic Cardiomyopathy (oHCM) across 2 companies.

How many clinical trials target Obstructive Hypertrophic Cardiomyopathy (oHCM)?

There are 3 clinical trials targeting Obstructive Hypertrophic Cardiomyopathy (oHCM) tracked by BioSniper.

Deep-dive into Obstructive Hypertrophic Cardiomyopathy (oHCM)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Obstructive Hypertrophic Cardiomyopathy (oHCM) — Drugs in Development & Clinical Trials | BioSniper